Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05733832 · ClinicalTrials.gov registry record · NA

A Trial of Post-Discharge Transitional Care for Patients With Chronic Liver Disease

A NA study of Liver Diseases, sponsored by Indiana University.

Recruiting
Registry status
NA
Development phase
1,000
Enrollment target
4
Study locations

NCT05733832 is a NA study of Liver Diseases that is actively recruiting participants, run by Indiana University. The registered enrollment target is 1,000 participants, below the 61,128-participant average among 33 other Liver Diseases trials with a reported enrollment target (98% lower). The trial reports 4 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05733832, a NA study of Liver Diseases, is actively recruiting participants, sponsored by Indiana University.

RECRUITING
Registry status
NA
Development phase
1,000 participants
Enrollment target
4
Study locations

Study Summary

Patients with complications of advanced liver disease often have difficulties after hospital discharge that result in early hospital readmission. Poor outcomes for these patients during this transitional time could be improved through the use of innovative transitional care models. This proposal aims to examine the effect of a transitional care model, The Transitional Liver Clinic (TLC), in reducing hospital re-admissions, improving quality of life, and improving patient experience.

Conditions Studied

Interventions

  • OTHER Transitional Liver Clinic (TLC)

Study Locations (4)

Illinois

  • University of Chicago - Chicago

Indiana

  • Indiana University Division of Gastroenterolgy and Hepatology - Indianapolis

Michigan

  • University of Michigan - Ann Arbor

Pennsylvania

  • Albert Einstein Healthcare Network - Philadelphia

Trial Details

FieldValue
Enrollment Target 1,000 participants
Start Date 2023-09-01
Est. Completion 2028-06-30
Phase NA

Sponsor

Indiana University

890 total trials

What the Registry Record Tells You About NCT05733832

The ClinicalTrials.gov registry entry for NCT05733832 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 61,128-participant average among 33 other Liver Diseases trials with a reported enrollment target (98% lower). The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Liver Diseases appearing as the primary indexed condition, and to 1 intervention - of which Transitional Liver Clinic (TLC) is the first listed.

NCT05733832 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Illinois, Indiana, Michigan.

Frequently Asked Questions

What is clinical trial NCT05733832 about?

NCT05733832 is a clinical study titled "A Trial of Post-Discharge Transitional Care for Patients With Chronic Liver Disease". Patients with complications of advanced liver disease often have difficulties after hospital discharge that result in early hospital readmission. Poor outcomes for these patients during this transitional time could be improved through the use of innovative transitional care models. This proposal aim...

What is the current status of trial NCT05733832?

This trial is currently recruiting. It is a NA study. The enrollment target is 1,000 participants. The study started on 2023-09-01. Estimated completion is 2028-06-30.

What conditions does trial NCT05733832 study?

This clinical trial studies the following conditions: Liver Diseases.

What interventions are being tested in trial NCT05733832?

The interventions under investigation include: Transitional Liver Clinic (TLC) (OTHER).

Who is sponsoring clinical trial NCT05733832?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05733832 being conducted?

This trial has 4 study locations across Illinois, Indiana, Michigan, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Liver Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.